Annals of Family Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Annals of Family Medicine 4:32-39 (2006)
© 2006 Annals of Family Medicine, Inc.
doi: 10.1370/afm.421
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow In Brief
Right arrow TRACK Comments: Submit a response
Right arrow TRACK Comments: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when TRACK Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenton, J. J.
Right arrow Articles by Young, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenton, J. J.
Right arrow Articles by Young, B. A.

Quality of Preventive Care for Diabetes: Effects of Visit Frequency and Competing Demands

Joshua J. Fenton, MD, MPH1, Michael Von Korff, ScD2, Elizabeth H.B. Lin, MD, MPH2, Paul Ciechanowski, MD, MPH3 and Bessie A. Young, MD, MPH4

1 Department of Family and Community Medicine, University of California, Davis, Sacramento, Calif
2 Center for Health Studies, Group Health Cooperative, Seattle, Wash
3 Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Wash
4 Department of Medicine, University of Washington, and Veterans Administration Hospital, Seattle, Wash


Figure 1
View larger version (14K):

[in a new window]
  		Figure 1. Receipt of diabetes preventive services by patterns of use.

HbA1C = hemoblogin A1C.

Note: Values are rates of receipt of services over a 2-year period. Microalbuminuria screening was assessed only in patients who did not have a prescription for an angiotension-converting enzyme inhibitor at baseline. Comparison of outcomes across use patterns are statistically significant (P <.001), except for the comparison of microalbuminuria screening (P = .05).

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Annals of Family Medicine.